{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:48Z","timestamp":1793196588240,"version":"4.5.0"},"reference-count":37,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8M1121"],"award-info":[{"award-number":["CMRPG8M1121"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Effective\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      (\n                      <jats:italic>H. pylori<\/jats:italic>\n                      ) eradication depends on maintaining intragastric pH &gt;6 and overcoming antibiotic resistance. High-dose dual therapy (HDDT) with a proton pump inhibitor (PPI) and amoxicillin has shown promising results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>\n                      To compare the efficacy of 14-day vonoprazan-based (VA) and esomeprazole-based (EA) HDDT for\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication and evaluate the impact of antibiotic resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Randomized controlled trial (RCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A total of 121 patients with confirmed\n                      <jats:italic>H. pylori<\/jats:italic>\n                      infection were randomized to receive either VA therapy (vonoprazan 20\u2009mg twice daily plus amoxicillin 750\u2009mg four times daily (QID)) or EA therapy (esomeprazole 40\u2009mg three times daily plus amoxicillin 750\u2009mg QID) for 14\u2009days. Eradication was assessed by the \u00b9\u00b3C-urea breath test at week 8. Antibiotic susceptibility testing was performed on cultured isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Baseline demographic and clinical characteristics were comparable between the VA and EA groups. In the intention-to-treat analysis, eradication rates were 86.9% (95% confidence interval (CI): 78.4%\u201395.4%) in the VA group and 81.7% (95% CI: 71.3%\u201389.4%) in the EA group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.430). Per-protocol (PP) analysis showed eradication rates of 93.0% (95% CI: 86.4%\u201399.6%) for VA and 84.5% (95% CI: 73.8%\u201392.1%) for EA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.150), indicating no statistically significant difference. Adverse events (AEs) were mild and similar between groups (5.3% in VA vs 5.2% in EA,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.983), with constipation and diarrhea being the most reported. Both groups achieved 100% compliance. Antibiotic resistance patterns did not significantly affect outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Both VA and EA-HDDT regimens demonstrated comparable efficacy, excellent compliance, and minimal AEs. Although VA therapy achieved a &gt;90% eradication rate in the PP analysis, our study was underpowered to confirm superiority. Therefore, larger, adequately powered RCTs are warranted to validate the potential superiority of VA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov: NCT06811207.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562848251378066","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:55:03Z","timestamp":1758369303000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-line\n                    <i>Helicobacter pylori<\/i>\n                    eradication: a randomized controlled trial"],"prefix":"10.1177","volume":"18","author":[{"given":"Wei-Chen","family":"Tai","sequence":"first","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"},{"name":"Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan"},{"name":"Department of Leisure and Sport Management, Cheng Shiu University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Sheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Cheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan"},{"name":"Kaohsiung Municipal Feng Shan Hospital\u2014under the Management of Chang Gung Medical Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Kun","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chien","family":"Yao","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan"},{"name":"Center for General Education, Cheng Shiu University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pao-Yuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chi","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8934-3223","authenticated-orcid":false,"given":"Seng-Kee","family":"Chuah","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6614-5937","authenticated-orcid":false,"given":"Chih-Ming","family":"Liang","sequence":"additional","affiliation":[{"name":"Division of Hepato-Gastroenterology, Kaohsiung Chang Gung Memorial Hospital, 123, Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung 833, Taiwan"},{"name":"Chang Gung University College of Medicine, Taoyuan City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2008.00633.x"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11051312"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2019.1542299"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9080436"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820976990"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2024.02.009"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00811-3"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8598.1"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12059"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.5056\/jnm18139"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13094"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.09.030"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2012.00960.x"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2008.01951.x"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05977.x"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.39.11.1279-a"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S213998"},{"key":"e_1_3_4_19_2","unstructured":"The European Committee on Antimicrobial Susceptibility Testing\u2014EUCAST. Archive of EUCAST tables and documents (v 12.0) https:\/\/www.eucast.org\/ast_of_bacteria\/previous_versions_of_documents\/ (2022 accessed 1 January 2022)."},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1049908"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-023-02042-2"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241309870"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123544"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.4103\/tcmj.tcmj_185_21"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062162"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.759249"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.938419"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2521-18"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001246"},{"issue":"5","key":"e_1_3_4_31_2","article-title":"Helicobacter pylori eradication therapy: still a challenge","volume":"13","author":"Hafeez M","year":"2021","unstructured":"Hafeez M, Qureshi ZA, Khattak AL, et al. Helicobacter pylori eradication therapy: still a challenge. Cureus 2021; 13(5): e14872.","journal-title":"Cureus"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014396"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13030211"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03404-7"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu17010053"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00754"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i13.100863"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02890-5"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848251378066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562848251378066","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848251378066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:24:42Z","timestamp":1758547482000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562848251378066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"alternative-id":["10.1177\/17562848251378066"],"URL":"https:\/\/doi.org\/10.1177\/17562848251378066","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"value":"1756-2848","type":"print"},{"value":"1756-2848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"article-number":"17562848251378066"}}